Our cohort of active MM patients (both NDMM and RRMM) exhibited statistically comparable proportions of Treg cells; however, the CD4+CD25+CD127− Treg subset was the only regulatory cell population found to tend to increase after therapy (p = 0.076). The gene discussed is CD4; the disease is Miyoshi myopathy.